Janux Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Janux Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • Janux Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.39M, a 87.7% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.39M +$1.12M +87.7% Dec 31, 2023 10-K 2024-03-08
Q4 2022 $1.27M +$763K +150% Dec 31, 2022 10-K 2024-03-08
Q4 2021 $510K +$276K +118% Dec 31, 2021 10-K 2024-03-08
Q4 2020 $234K +$85K +57% Dec 31, 2020 10-K 2023-03-10
Q4 2019 $149K Dec 31, 2019 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.